Shenzhen Chipscreen Biosciences Co (688321) - Total Liabilities

Latest as of September 2025: CN¥1.98 Billion CNY ≈ $289.34 Million USD

Based on the latest financial reports, Shenzhen Chipscreen Biosciences Co (688321) has total liabilities worth CN¥1.98 Billion CNY (≈ $289.34 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Shenzhen Chipscreen Biosciences Co (688321) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Shenzhen Chipscreen Biosciences Co - Total Liabilities Trend (2016–2024)

This chart illustrates how Shenzhen Chipscreen Biosciences Co's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Shenzhen Chipscreen Biosciences Co's balance sheet.

Shenzhen Chipscreen Biosciences Co Competitors by Total Liabilities

The table below lists competitors of Shenzhen Chipscreen Biosciences Co ranked by their total liabilities.

Company	Country	Total Liabilities
Shenzhen Ysstech Info-Tech Co Ltd SHE:300377	China	CN¥219.20 Million
Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd SHE:002100	China	CN¥9.60 Billion
Advtech JSE:ADH	South Africa	ZAC4.68 Billion
Zhuzhou Times New Material Technology Co Ltd SHG:600458	China	CN¥18.32 Billion
NV5 Global Inc NASDAQ:NVEE	USA	$440.77 Million
Adecoagro S.A F:ACD	Germany	€3.37 Billion
Peptron Inc KQ:087010	Korea	₩38.50 Billion
Ardent Health Partners, Inc. NYSE:ARDT	USA	$3.54 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Shenzhen Chipscreen Biosciences Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Shenzhen Chipscreen Biosciences Co to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.87	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.19	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.54	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shenzhen Chipscreen Biosciences Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shenzhen Chipscreen Biosciences Co (2016–2024)

The table below shows the annual total liabilities of Shenzhen Chipscreen Biosciences Co from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥1.67 Billion ≈ $244.34 Million	+11.82%
2023-12-31	CN¥1.49 Billion ≈ $218.52 Million	+13.12%
2022-12-31	CN¥1.32 Billion ≈ $193.17 Million	+176.87%
2021-12-31	CN¥476.79 Million ≈ $69.77 Million	+105.12%
2020-12-31	CN¥232.44 Million ≈ $34.01 Million	-5.16%
2019-12-31	CN¥245.10 Million ≈ $35.87 Million	+2.36%
2018-12-31	CN¥239.44 Million ≈ $35.04 Million	+16.53%
2017-12-31	CN¥205.47 Million ≈ $30.07 Million	+8.30%
2016-12-31	CN¥189.73 Million ≈ $27.76 Million	--

About Shenzhen Chipscreen Biosciences Co

SHG:688321 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.51 Billion

CN¥10.34 Billion CNY

Market Cap Rank

#7216 Global

#1556 in China

Share Price

CN¥25.35

Change (1 day)

-3.17%

52-Week Range

CN¥23.68 - CN¥35.25

All Time High

CN¥102.00